Results 151 to 160 of about 527,601 (286)
P02.319 Antipsychotic treatment, adverse events and health-related quality of life [PDF]
X Badia+5 more
openalex +1 more source
This study introduces a paper‐based biodegradable, humidity‐insensitive e‐nose for real‐time breath analysis, addressing challenges in existing technologies such as humidity interference, high costs, and environmental impact. Featuring hydrophobic polymer coatings, these sensors reliably detect VOCs even in high‐moisture environments.
Indrajit Mondal+2 more
wiley +1 more source
Oct4‐nanoscript, a biomimetic nanoparticle‐based artificial transcription factor, precisely regulates cellular rejuvenation by activating Oct4 target genes, restoring epigenetic marks, and reducing DNA damage. In a progeria model, it effectively rescued aging‐associated pathologies and extended lifespan.
Hongwon Kim+8 more
wiley +1 more source
This review highlights recent advances in engineering artificial antigen‐presenting cells (aAPCs) as alternatives to dendritic cells for T cell expansion. Key design principles inspired by the immunological synapse are discussed, with emphasis on strategies for polyclonal and antigen‐specific T cell expansion.
Nguyen Thi Nguyen, Yu Seok Youn
wiley +1 more source
MDDC: An R and Python package for adverse event identification in pharmacovigilance data. [PDF]
Liu A, Mukhopadhyay R, Markatou M.
europepmc +1 more source
Intravascular ultrasound predictors of major adverse cardiac events in patients with unstable angina
Mariann Gyöngyösi+6 more
openalex +1 more source
VA releases adverse event data: Clinicians must report to nationwide system [PDF]
Nancy Tarleton Landis
openalex +1 more source
Intraoral Drug Delivery: Bridging the Gap Between Academic Research and Industrial Innovations
Intraoral drug delivery offers a promising route for systemic and localized therapies, yet challenges such as enzymatic degradation, limited permeability, and microbial interactions hinder efficacy. This figure highlights innovative strategies—mucoadhesive materials, enzyme inhibitors, and permeation enhancers—to overcome these barriers.
Soheil Haddadzadegan+4 more
wiley +1 more source
Corrigendum: Mining and analysis of dizziness adverse event signals in postoperative analgesia patients based on the FDA adverse event reporting system database. [PDF]
Zhou F, He H, Gao J, Zhang Z.
europepmc +1 more source